The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Patricia Ho(Columbia University Irving Medical Center), Johannes C. Melms(Columbia University Irving Medical Center), Meri Rogava(Columbia University Irving Medical Center), Chris J. Frangieh(Broad Institute), Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Shivem B. Shah(Columbia University Irving Medical Center), Zachary Walsh(Columbia University Irving Medical Center), Oleksandr Kyrysyuk(Dana-Farber Cancer Institute), Amit Dipak Amin(Columbia University Irving Medical Center), Lindsay Caprio(Columbia University Irving Medical Center), Benjamin T. Fullerton(Columbia University), Rajesh K. Soni(Columbia University), Casey R. Ager(Columbia University Irving Medical Center), Jana Biermann(Columbia University), Yi‐Ping Wang(Columbia University), Mohsen Khosravi‐Maharlooei(Mayo Clinic in Arizona), Giorgia Zanetti(Columbia University), Michael Mu(Columbia University Irving Medical Center), Hijab Fatima(Columbia University), Emily K. Moore(Columbia University Irving Medical Center), Neil Vasan(Columbia University Irving Medical Center), Samuel F. Bakhoum(Memorial Sloan Kettering Cancer Center), Steven L. Reiner(Columbia University), Chantale Bernatchez(The University of Texas MD Anderson Cancer Center), Megan Sykes(Columbia University), Emily M. Mace(Columbia University), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Dirk Schadendorf(Essen University Hospital), Oliver Bechter(KU Leuven), Parin Shah(Columbia University), Gary K. Schwartz(Columbia University Irving Medical Center), Jean‐Christophe Marine(VIB-KU Leuven Center for Cancer Biology), Benjamin Izar(Columbia University Irving Medical Center)
Cited by 92Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis